{"transactions":[{"id":804408,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chair, CEO and President"}}],"security":"Warrant (right to buy)","published_at":"2026-04-20T12:52:50.000Z","date":"2026-04-17","kind":"sale","planned":false,"acquired":false,"shares":650000,"price":0.1538,"value":99970.0,"ownership":{"direct":true},"balance_after":2600000,"derivative":{"exercise_price":1.2,"exercise_date":"2026-04-16","expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001193125-26-162846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000119312526162846/ownership.xml","form_type":"4"}},{"id":804407,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chair, CEO and President"}}],"security":"Warrant (right to buy)","published_at":"2026-04-20T12:52:50.000Z","date":"2026-04-16","kind":"purchase","planned":false,"acquired":true,"shares":3250000,"price":0.1538,"value":499850.0,"ownership":{"direct":true},"balance_after":3250000,"derivative":{"exercise_price":1.2,"exercise_date":"2026-04-16","expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":3250000},"source":{"system":"sec-edgar","filing":"0001193125-26-162846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000119312526162846/ownership.xml","form_type":"4"}},{"id":1020776,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-10-09T12:42:24.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Notwithstanding the preceding sentence, the shares of Common Stock subject to the Option will not be exercisable until such date as the Issuer's outstanding indebtedness under the Senior Secured Promissory Note issued by the Issuer to Oramed Pharmaceuticals, Inc. on September 21, 2023 and the Tranche B Senior Secured Convertible Notes issued by the Issuer to each of Oramed Pharmaceuticals, Inc., Nomis Bay Ltd., 3i LP and BPY Limited, has been repaid in full."}],"balance_after":120000,"derivative":{"exercise_price":17.58,"expiration_date":"2035-10-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-25-235241","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000119312525235241/ownership.xml","form_type":"4"}},{"id":1378797,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2024-10-31T16:44:57.000Z","date":"2024-10-31","kind":"purchase","planned":false,"acquired":true,"shares":8888,"price":0.9396,"value":8351.1648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 8,888 shares of common stock, par value $0.0001 per share (the \"Common Stock\")."}],"balance_after":320161,"source":{"system":"sec-edgar","filing":"0000950170-24-119394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017024119394/ownership.xml","form_type":"4"}},{"id":1384037,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2024-10-18T13:08:55.000Z","date":"2024-10-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.971,"value":9710.0,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.0001 per share (the \"Common Stock\")."}],"balance_after":60070,"source":{"system":"sec-edgar","filing":"0000950170-24-115449","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017024115449/ownership.xml","form_type":"4"}},{"id":1475138,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-19T01:26:53.000Z","date":"2024-06-18","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":194000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000950170-24-075213","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017024075213/ownership.xml","form_type":"4"}},{"id":1475137,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2024-06-19T01:26:53.000Z","date":"2024-06-18","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":1.41,"value":8460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":311273,"source":{"system":"sec-edgar","filing":"0000950170-24-075213","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017024075213/ownership.xml","form_type":"4"}},{"id":1511236,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2024-05-17T22:42:21.000Z","date":"2024-05-17","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.8797,"value":43985.0,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market purchase by the reporting person of 50,000 shares of common stock, par value $0.0001 per share (the \"Common Stock\"). The number of shares of Common Stock reported represents an aggregate number of shares purchased in multiple open market transactions over a range of sales prices."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on May 17, 2024 at prices ranging from $0.8700 to $0.8800 per share, inclusive. The amount reflected has been rounded to 4 decimal points."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range."}],"balance_after":50070,"source":{"system":"sec-edgar","filing":"0000950170-24-062009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017024062009/ownership.xml","form_type":"4"}},{"id":1764319,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-10-06T01:35:29.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-23-052259","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017023052259/ownership.xml","form_type":"4"}},{"id":1944406,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2023-03-20T21:19:03.000Z","date":"2023-03-17","kind":"other","planned":false,"acquired":true,"shares":2730,"price":8.6002,"value":23478.546,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 30, 2022, the Board of Directors of Sorrento Therapeutics, Inc. (\"Sorrento\") declared a stock dividend (the \"Dividend\") to all holders of record of its common stock as of the close of business on January 9, 2023, of 0.1410127 of a share of common stock, par value $0.0001 per share, of the Issuer (\"Scilex Common Stock\") for each one share of common stock, par value $0.0001 per share, of Sorrento (\"Sorrento Common Stock\"). The Reporting Person wrote a put option in Sorrento Common Stock on August 26, 2022 (the \"Put Option\"), which was adjusted as a result of the Stock Dividend to relate to an aggregate of 19,500 shares of Sorrento Common Stock and 2,730 shares of Scilex Common Stock and to reflect a corresponding change to the exercise price of the Put Option to $0.80268 per share of Sorrento Common Stock and $8.6002 per share of Scilex Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from footnote 1) The Put Option settled on March 17, 2023 and resulted in the Reporting Person acquiring 2,730 shares of Scilex Common Stock at a price of $8.6002 per share of Scilex Common Stock, in addition to 19,500 shares of Sorrento Common Stock at a price of $0.80268 per share of Sorrento Common Stock."}],"balance_after":2730,"source":{"system":"sec-edgar","filing":"0000899243-23-009127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000089924323009127/doc4.xml","form_type":"4"}},{"id":1945247,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Put Option (obligation to buy)","published_at":"2023-03-20T19:52:53.000Z","date":"2023-03-17","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":195,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"balance_after":0,"derivative":{"exercise_price":0.8027,"exercise_date":"2022-08-26","expiration_date":"2023-03-17","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0000899243-23-009159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924323009159/doc4.xml","form_type":"4"}},{"id":1945246,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-20T19:52:53.000Z","date":"2023-03-17","kind":"other","planned":false,"acquired":true,"shares":19500,"price":0.8027,"value":15652.65,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 30, 2022, the Issuer's Board of Directors declared a stock dividend (the \"Dividend\") to all holders of record of its common stock as of the close of business on January 9, 2023, of 0.1410127 of a share of common stock, par value $0.0001 per share, of Scilex Holding Company (\"Scilex Common Stock\") for each one share of common stock, par value $0.0001 per share, of the Issuer (\"Sorrento Common Stock\"). The Put Option written by the Reporting Person on August 26, 2022 (the \"Put Option\") was previously reported at an exercise price of $5.50 per share of Sorrento Common Stock, which was adjusted as a result of the Dividend to relate to an aggregate of 19,500 shares of Sorrento Common Stock and 2,730 shares of Scilex Common Stock and to reflect a corresponding change to the exercise price of the Put Option to $0.80268 per share of Sorrento Common Stock and $8.6002 per share of Scilex Common Stock. The Put Option settled on March 17, 2023 and resulted in the Reporting Person"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued Footnote 1) acquiring 19,500 shares of Sorrento Common Stock at a price of $0.80268 per share of Sorrento Common Stock, in addition to 2,730 shares of Scilex Common Stock at a price of $8.6002 per share of Scilex Common Stock."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-23-009159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924323009159/doc4.xml","form_type":"4"}},{"id":2053710,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T22:21:09.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":9000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":9000000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":9000000},"source":{"system":"sec-edgar","filing":"0000899243-23-001866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000089924323001866/doc4.xml","form_type":"4"}},{"id":2077193,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Put Option (obligation to buy)","published_at":"2022-12-23T14:28:10.000Z","date":"2022-12-21","kind":"other","acquired":false,"shares":3,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"balance_after":195,"derivative":{"exercise_price":5.5,"exercise_date":"2022-08-26","expiration_date":"2023-03-17","underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001209191-22-062586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122062586/doc4.xml","form_type":"4"}},{"id":2077192,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Put Option (obligation to buy)","published_at":"2022-12-23T14:28:10.000Z","date":"2022-12-02","kind":"other","acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"balance_after":198,"derivative":{"exercise_price":5.5,"exercise_date":"2022-08-26","expiration_date":"2023-03-17","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001209191-22-062586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122062586/doc4.xml","form_type":"4"}},{"id":2077191,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-12-23T14:28:10.000Z","date":"2022-12-21","kind":"other","acquired":true,"shares":300,"price":5.5,"value":1650.0,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"balance_after":500,"source":{"system":"sec-edgar","filing":"0001209191-22-062586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122062586/doc4.xml","form_type":"4"}},{"id":2077190,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-12-23T14:28:10.000Z","date":"2022-12-02","kind":"other","acquired":true,"shares":200,"price":5.5,"value":1100.0,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"balance_after":200,"source":{"system":"sec-edgar","filing":"0001209191-22-062586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122062586/doc4.xml","form_type":"4"}},{"id":2084434,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-12-16T20:10:21.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The grant to the Reporting Person of a restricted stock unit award for 1,500,000 shares of the Issuer's common stock (the \"RSU Award\") was approved by the compensation committee of the board of directors of the Issuer on September 1, 2022 and was granted to the Reporting Person on September 2, 2022. The RSU Award was conditioned upon and subject to the Issuer's stockholders approving an amendment to the Issuer's 2019 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder (the \"Plan Amendment\"). The Issuer's stockholders approved the Plan Amendment on December 15, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities are shares subject to the RSU Award. 1/4th of the shares subject to the RSU Award shall vest on September 2, 2023 and 1/4th of the shares\nsubject to the RSU Award shall vest on each anniversary thereafter."}],"balance_after":6265805,"source":{"system":"sec-edgar","filing":"0001209191-22-061746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122061746/doc4.xml","form_type":"4"}},{"id":2164729,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Call Option (right to buy)","published_at":"2022-09-07T18:22:33.000Z","date":"2022-09-07","kind":"purchase","acquired":true,"shares":129,"price":41.66,"value":5374.14,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"balance_after":129,"derivative":{"exercise_price":12,"exercise_date":"2022-09-07","expiration_date":"2024-01-19","underlying":"Common Stock","underlying_shares":12900},"source":{"system":"sec-edgar","filing":"0001209191-22-049065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122049065/doc4.xml","form_type":"4"}},{"id":2164728,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Call Option (right to buy)","published_at":"2022-09-07T18:22:33.000Z","date":"2022-09-07","kind":"purchase","acquired":true,"shares":759,"price":40.66,"value":30860.94,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"balance_after":759,"derivative":{"exercise_price":12,"exercise_date":"2022-09-07","expiration_date":"2024-01-19","underlying":"Common Stock","underlying_shares":75900},"source":{"system":"sec-edgar","filing":"0001209191-22-049065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122049065/doc4.xml","form_type":"4"}},{"id":2164727,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-07T18:22:33.000Z","date":"2022-09-07","kind":"purchase","acquired":true,"shares":88888,"price":2.0177,"value":179349.3176,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.01 to $2.02, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."}],"balance_after":4765805,"source":{"system":"sec-edgar","filing":"0001209191-22-049065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122049065/doc4.xml","form_type":"4"}},{"id":2166589,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-06T17:24:30.000Z","date":"2022-09-06","kind":"purchase","acquired":true,"shares":55555,"price":1.9599,"value":108882.2445,"ownership":{"direct":true},"balance_after":4676917,"source":{"system":"sec-edgar","filing":"0001209191-22-048811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122048811/doc4.xml","form_type":"4"}},{"id":2168305,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-02T16:31:50.000Z","date":"2022-09-02","kind":"grant","acquired":true,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, 1/4th of which shall vest on September 2, 2023 and 1/4th of which shall vest on each anniversary thereafter."}],"balance_after":4621362,"source":{"system":"sec-edgar","filing":"0001209191-22-048514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122048514/doc4.xml","form_type":"4"}},{"id":2173427,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Put Option (obligation to buy)","published_at":"2022-08-26T17:33:42.000Z","date":"2022-08-26","kind":"sale","acquired":false,"shares":200,"price":349.3298,"value":69865.96,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"balance_after":200,"derivative":{"exercise_price":5.5,"exercise_date":"2022-08-26","expiration_date":"2023-03-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-047741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122047741/doc4.xml","form_type":"4"}},{"id":2173426,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-26T17:33:42.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":33333,"price":2.11,"value":70332.63,"ownership":{"direct":true},"balance_after":2121362,"source":{"system":"sec-edgar","filing":"0001209191-22-047741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122047741/doc4.xml","form_type":"4"}},{"id":2174370,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Call Option (right to buy)","published_at":"2022-08-25T17:18:13.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":1000,"price":30.66,"value":30660.0,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"balance_after":1000,"derivative":{"exercise_price":15,"exercise_date":"2022-08-25","expiration_date":"2024-01-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-047558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122047558/doc4.xml","form_type":"4"}},{"id":2174369,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-25T17:18:13.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":22222,"price":2.0596,"value":45768.4312,"ownership":{"direct":true},"balance_after":2088029,"source":{"system":"sec-edgar","filing":"0001209191-22-047558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122047558/doc4.xml","form_type":"4"}},{"id":2233351,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-06-14T17:15:20.000Z","date":"2022-06-14","kind":"purchase","acquired":true,"shares":10000,"price":1.3999,"value":13999.0,"ownership":{"direct":true},"balance_after":2065807,"source":{"system":"sec-edgar","filing":"0001209191-22-036760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122036760/doc4.xml","form_type":"4"}},{"id":2557122,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Non-qualified stock options","published_at":"2021-09-29T14:35:02.000Z","date":"2021-09-29","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in four equal annual installments on January 1, 2013, January 1, 2014, January 1, 2015 and January 1, 2016, respectively."}],"balance_after":0,"derivative":{"exercise_price":4,"expiration_date":"2022-02-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-058036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919121058036/doc4.xml","form_type":"4"}},{"id":2557121,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-29T14:35:02.000Z","date":"2021-09-29","kind":"exercise","acquired":true,"shares":10000,"price":4,"value":40000.0,"ownership":{"direct":true},"balance_after":2055807,"source":{"system":"sec-edgar","filing":"0001209191-21-058036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919121058036/doc4.xml","form_type":"4"}},{"id":2587354,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2021-08-30T20:16:55.000Z","date":"2021-08-30","kind":"grant","acquired":true,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the original number of shares subject to the option shall vest on August 30, 2022, and 1/48th of the original number of shares subject to the option shall vest following each one month period of service after August 30, 2022, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":2500000,"derivative":{"exercise_price":8.86,"expiration_date":"2031-08-30","underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001209191-21-053987","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919121053987/doc4.xml","form_type":"4"}},{"id":3003398,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-10-20T09:00:15.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":24935882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The performance-based stock option award (the \"Award\") was approved by the compensation committee of the board of directors of the Issuer on August 7, 2020, subject to stockholder approval of the Award. The Issuer's stockholders approved the Award on October 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Award will vest in nine tranches of 2,493,588 shares and a final tranche of 2,493,590 shares, in each case upon the market capitalization of the Issuer's common stock reaching certain milestone thresholds."}],"balance_after":24935882,"derivative":{"exercise_price":17.3,"expiration_date":"2030-08-07","underlying":"Common Stock","underlying_shares":24935882},"source":{"system":"sec-edgar","filing":"0001104659-20-116285","document":"tm2033858d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465920116285/tm2033858d1_4.xml","form_type":"4"}},{"id":3111127,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options","published_at":"2020-06-15T18:08:22.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the original number of shares subject to the option shall vest on June 15, 2021, and 1/48th of the original number of shares subject to the option shall vest following each one month period of service after June 15, 2021, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":1500000,"derivative":{"exercise_price":4.89,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0000850261-20-000040","document":"wf-form4_159225888472376.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026120000040/wf-form4_159225888472376.xml","form_type":"4"}},{"id":3551256,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options","published_at":"2019-04-23T21:01:38.000Z","date":"2019-04-19","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the original number of shares subject to the option shall vest on April 14, 2020 and 1/48th of the original number of shares subject to the option shall vest following each one month period of service after April 14, 2020, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":1500000,"derivative":{"exercise_price":3.78,"expiration_date":"2029-04-19","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0000850261-19-000013","document":"wf-form4_155606768210161.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026119000013/wf-form4_155606768210161.xml","form_type":"4"}},{"id":3863147,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-07-23T06:50:29.000Z","date":"2018-07-20","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vested over a four-year period commencing on February 16, 2010, with 25% of the shares subject to the option vesting on each anniversary of the vesting commencement date. The shares were fully vested as of February 16, 2014."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2020-02-16","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000850261-18-000029","document":"wf-form4_153234301298903.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026118000029/wf-form4_153234301298903.xml","form_type":"4"}},{"id":3863146,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-07-23T06:50:29.000Z","date":"2018-07-20","kind":"exercise","acquired":true,"shares":6000,"price":1.75,"value":10500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Since February 28, 2018, the date of the Reporting Person's last Form 4 disclosing holdings under Table I of Form 4 (the \"Prior Form 4\"), the Reporting Person has transferred shares of Common Stock among his direct holdings, the holdings of his spouse, the holdings of family trusts of which the Reporting Person is co-trustee with his spouse and the holdings of an entity of which the Reporting Person and his spouse are the sole members and managing directors. 2,999 shares of Common Stock beneficially owned by the Reporting Person were also inadvertently omitted from the Prior Form 4."}],"balance_after":2045807,"source":{"system":"sec-edgar","filing":"0000850261-18-000029","document":"wf-form4_153234301298903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026118000029/wf-form4_153234301298903.xml","form_type":"4"}},{"id":3929454,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options","published_at":"2018-05-17T21:01:49.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the original number of shares subject to the option shall vest on May 17, 2019 and 1/48th of the original number of shares subject to the option shall vest following each one month period of service after May 17, 2019, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":750000,"derivative":{"exercise_price":7.2,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0000850261-18-000021","document":"wf-form4_152660529478377.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026118000021/wf-form4_152660529478377.xml","form_type":"4"}},{"id":4028667,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-28T19:04:27.000Z","date":"2018-02-28","kind":"purchase","acquired":true,"shares":64600,"price":9.95,"value":642770.0,"ownership":{"direct":true},"balance_after":1906177,"source":{"system":"sec-edgar","filing":"0000850261-18-000009","document":"wf-form4_151986264772624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026118000009/wf-form4_151986264772624.xml","form_type":"4"}},{"id":4028666,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-28T19:04:27.000Z","date":"2018-02-28","kind":"other","acquired":true,"shares":124298,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a stock purchase agreement by and among the Issuer, Scilex Pharmaceuticals Inc. (\"Scilex\"), the stockholders of Scilex party thereto and SPI Shareholders Representative, LLC, as representative of the Scilex Stockholders (the \"Stock Purchase Agreement\"), an entity of which the Reporting Person and his spouse are the sole members and managing directors sold 1,368,681 shares of common stock of Scilex to the Issuer and, upon the achievement of a milestone on February 28, 2018, the Issuer issued such entity 124,298 shares of the common stock of the Issuer. The Stock Purchase Agreement, which was entered into on November 8, 2016, placed a value on the Issuer's common stock of $9.95 per share. Contingent upon the achievement of such milestone, such entity's right to receive such shares became fixed and irrevocable on November 8, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a stock purchase agreement by and among the Issuer, Scilex Pharmaceuticals Inc. (\"Scilex\"), the stockholders of Scilex party thereto and SPI Shareholders Representative, LLC, as representative of the Scilex Stockholders (the \"Stock Purchase Agreement\"), an entity of which the Reporting Person and his spouse are the sole members and managing directors sold 1,368,681 shares of common stock of Scilex to the Issuer and, upon the achievement of a milestone on February 28, 2018, the Issuer issued such entity 124,298 shares of the common stock of the Issuer. The Stock Purchase Agreement, which was entered into on November 8, 2016, placed a value on the Issuer's common stock of $9.95 per share. Contingent upon the achievement of such milestone, such entity's right to receive such shares became fixed and irrevocable on November 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by an entity of which the Reporting Person and his spouse are the sole members and managing directors."}],"balance_after":260161,"source":{"system":"sec-edgar","filing":"0000850261-18-000009","document":"wf-form4_151986264772624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026118000009/wf-form4_151986264772624.xml","form_type":"4"}},{"id":4093977,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock Warrant (right to buy)","published_at":"2018-01-22T07:28:50.000Z","date":"2018-01-21","kind":"purchase","acquired":true,"shares":261438,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On January 21, 2018, the Reporting Person entered into a Securities Purchase Agreement (the \"SPA\") with a third party whereby the Reporting Person agreed to purchase from the third party, and the third party agreed to sell to the Reporting Person, an aggregate of 1,801,801 shares of the Issuer's common stock (the \"Shares\") and a warrant to purchase an aggregate of 261,438 shares of the Issuer's common stock (the \"Warrant\"). The closing of the purchase and sale of the Shares and the Warrant as contemplated by the SPA has not yet occurred, but is expected to close no later than February 19, 2018. As the closing of the purchase and sale of the Shares and the Warrant is not subject to satisfaction of material conditions beyond the control of the parties, the Reporting Person is reporting the purchase of the Shares and the Warrant at this time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The aggregate purchase price for the Shares and the Warrant pursuant to the SPA is $11,531,526.40."}],"balance_after":261438,"derivative":{"exercise_price":8.5,"exercise_date":"2016-06-07","expiration_date":"2019-06-07","underlying":"Common Stock","underlying_shares":261438},"source":{"system":"sec-edgar","filing":"0001144204-18-002932","document":"tv483718_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/850261/000114420418002932/tv483718_4.xml","form_type":"4"}},{"id":4093976,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-22T07:28:50.000Z","date":"2018-01-21","kind":"purchase","acquired":true,"shares":1801801,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On January 21, 2018, the Reporting Person entered into a Securities Purchase Agreement (the \"SPA\") with a third party whereby the Reporting Person agreed to purchase from the third party, and the third party agreed to sell to the Reporting Person, an aggregate of 1,801,801 shares of the Issuer's common stock (the \"Shares\") and a warrant to purchase an aggregate of 261,438 shares of the Issuer's common stock (the \"Warrant\"). The closing of the purchase and sale of the Shares and the Warrant as contemplated by the SPA has not yet occurred, but is expected to close no later than February 19, 2018. As the closing of the purchase and sale of the Shares and the Warrant is not subject to satisfaction of material conditions beyond the control of the parties, the Reporting Person is reporting the purchase of the Shares and the Warrant at this time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The aggregate purchase price for the Shares and the Warrant pursuant to the SPA is $11,531,526.40."}],"balance_after":1841577,"source":{"system":"sec-edgar","filing":"0001144204-18-002932","document":"tv483718_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000114420418002932/tv483718_4.xml","form_type":"4"}},{"id":4208820,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options","published_at":"2017-09-15T21:46:30.000Z","date":"2017-09-14","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the original number of shares subject to the option shall vest on September 14, 2018 and 1/48 of the original number of shares subject to the option shall vest following each one month period of service after September 14, 2018, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":750000,"derivative":{"exercise_price":1.8,"expiration_date":"2027-09-14","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001144204-17-048363","document":"v475329_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000114420417048363/v475329_4.xml","form_type":"4"}},{"id":4208813,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-09-15T21:27:39.000Z","date":"2017-09-11","kind":"other","acquired":true,"shares":67932,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a stock purchase agreement by and among the Issuer, Scilex Pharmaceuticals Inc. (\"Scilex\"), the stockholders of Scilex party thereto and SPI Shareholders Representative, LLC, as representative of the Scilex Stockholders (the \"Stock Purchase Agreement\"), an entity of which the Reporting Person and his spouse are the sole members and managing directors sold 1,368,681 shares of common stock of Scilex to the Issuer and, upon the achievement of a milestone on September 11, 2017, the Issuer issued such entity 67,932 shares of the common stock of the Issuer. The Stock Purchase Agreement, which was entered into on November 8, 2016, placed a value on the Issuer's common stock of $6.33 per share. Contingent upon the achievement of such milestone, such entity's right to receive such shares became fixed and irrevocable on November 8, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a stock purchase agreement by and among the Issuer, Scilex Pharmaceuticals Inc. (\"Scilex\"), the stockholders of Scilex party thereto and SPI Shareholders Representative, LLC, as representative of the Scilex Stockholders (the \"Stock Purchase Agreement\"), an entity of which the Reporting Person and his spouse are the sole members and managing directors sold 1,368,681 shares of common stock of Scilex to the Issuer and, upon the achievement of a milestone on September 11, 2017, the Issuer issued such entity 67,932 shares of the common stock of the Issuer. The Stock Purchase Agreement, which was entered into on November 8, 2016, placed a value on the Issuer's common stock of $6.33 per share. Contingent upon the achievement of such milestone, such entity's right to receive such shares became fixed and irrevocable on November 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by an entity of which the Reporting Person and his spouse are the sole members and managing directors."}],"balance_after":135863,"source":{"system":"sec-edgar","filing":"0001144204-17-048349","document":"v475332_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000114420417048349/v475332_4.xml","form_type":"4"}},{"id":4281595,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-15T16:20:05.000Z","date":"2017-06-15","kind":"purchase","acquired":true,"shares":9000,"price":1.84,"value":16560.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":29001,"source":{"system":"sec-edgar","filing":"0001144204-17-032732","document":"v469087_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000114420417032732/v469087_4.xml","form_type":"4"}},{"id":4281594,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-15T16:20:05.000Z","date":"2017-06-15","kind":"purchase","acquired":true,"shares":20001,"price":1.8,"value":36001.8,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":20001,"source":{"system":"sec-edgar","filing":"0001144204-17-032732","document":"v469087_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000114420417032732/v469087_4.xml","form_type":"4"}},{"id":4350193,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-04-19T16:12:21.000Z","date":"2017-04-19","kind":"purchase","acquired":true,"shares":100000,"price":2,"value":200000.0,"ownership":{"direct":true},"balance_after":139776,"source":{"system":"sec-edgar","filing":"0001144204-17-021046","document":"v464547_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000114420417021046/v464547_4.xml","form_type":"4"}},{"id":4433440,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-22T17:08:46.000Z","date":"2017-02-22","kind":"purchase","acquired":true,"shares":2000,"price":5.6,"value":11200.0,"ownership":{"direct":true},"balance_after":39776,"source":{"system":"sec-edgar","filing":"0000899243-17-004969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924317004969/doc4.xml","form_type":"4"}},{"id":4458181,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-10T19:43:13.000Z","date":"2017-02-10","kind":"purchase","acquired":true,"shares":20000,"price":5.15,"value":103000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This amended report on Form 4 is being filed to amend the Form 4 filed by the reporting person on February 3, 2017 to correct the transaction date, which was inadvertently reported as February 3, 2017."}],"balance_after":37776,"source":{"system":"sec-edgar","filing":"0000899243-17-003639","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924317003639/doc4a.xml","form_type":"4/A","original_submission_date":"2017-02-03"}},{"id":4469965,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-03T19:47:15.000Z","date":"2017-02-03","kind":"purchase","acquired":true,"shares":20000,"price":5.15,"value":103000.0,"ownership":{"direct":true},"balance_after":37776,"source":{"system":"sec-edgar","filing":"0000899243-17-002783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924317002783/doc4.xml","form_type":"4"}},{"id":4559237,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options","published_at":"2016-11-14T20:10:16.000Z","date":"2016-11-11","kind":"other","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 11, 2016, the Issuer and the Reporting Person agreed to rescind 200,000 of the shares subject to the option to purchase 500,000 shares of the Issuer's common stock that was granted to the Reporting Person on August 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 11, 2016, the Issuer and the Reporting Person agreed to rescind 200,000 of the shares subject to the option to purchase 500,000 shares of the Issuer's common stock that was granted to the Reporting Person on August 12, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the 300,000 shares remaining subject to the option shall vest on August 12, 2017 and 1/48 of the original number of shares subject to the option shall vest following each one month period of service after August 12, 2017, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":6.52,"expiration_date":"2026-08-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-16-033416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924316033416/doc4.xml","form_type":"4"}},{"id":4562983,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-11-09T20:31:36.000Z","date":"2016-11-08","kind":"grant","acquired":true,"shares":67931,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a stock purchase agreement by and among the Issuer, Scilex Pharmaceuticals Inc. (\"Scilex\"), the stockholders of Scilex party thereto (the \"Scilex Stockholders\") and SPI Shareholders Representative, LLC, as representative of the Scilex Stockholders (the \"Stock Purchase Agreement\"), an entity of which the Reporting Person and his spouse are the sole members and managing directors (the \"Entity\") sold 1,368,681 shares of common stock of Scilex to the Issuer in exchange for 67,931 shares of common stock of the Issuer.  The Stock Purchase Agreement, which was entered into on November 8, 2016, placed a value on the Issuer's common stock of $6.33 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Of the 67,931 shares issued to the Entity pursuant to the Stock Purchase Agreement, 13,586 are currently being held in escrow and are subject to forfeiture until May 8, 2017 to satisfy claims arising as a result of Scilex's or the Entity's breach of their representations, warranties or covenants contained in the Stock Purchase Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by an entity of which the Reporting Person and his spouse are the sole members and managing directors."}],"balance_after":67931,"source":{"system":"sec-edgar","filing":"0000899243-16-033101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924316033101/doc4.xml","form_type":"4"}}]}